← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:401 | 401 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1157 | 5446-1157-03 | Chloramphenicol; Sulfamethoxazole; Amphotericin B | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:401 | 401 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:401 | 401 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine; Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:401 | 401 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-227 | 70324-227-01 | Epinephrine | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:401 | 401 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1350 | 61141-1350-5 | Ephedrine Sulfate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:401 | 401 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:401 | 401 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-013 | 71449-013-05 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:401 | 401 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-7 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:401 | 401 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2109 | 72627-2109-3 | Estradiol Cypionate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:401 | 401 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3025 | 79559-3025-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:401 | 401 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-201 | 73702-201-10 | Fentanyl | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:401 | 401 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-684 | 70092-684-48 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:401 | 401 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:401 | 401 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-25 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:401 | 401 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-444 | 70092-444-05 | Fentanyl Citrate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:402 | 402 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0427 | 71285-0427-1 | Trophamine 3% / Dextrose 5% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:402 | 402 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69623-122 | 69623-122-28 | Chlorpromazine | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:402 | 402 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:402 | 402 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine; Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:402 | 402 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70731-231 | 70731-231-86 | Epinephrine | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:402 | 402 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1374 | 61141-1374-5 | Ephedrine Sulfate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:402 | 402 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:402 | 402 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-013 | 71449-013-32 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:402 | 402 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-4 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:402 | 402 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5342 | 26436-5342-1 | Estriol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:402 | 402 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-144 | 70713-144-01 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:402 | 402 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-203 | 73702-203-65 | Fentanyl | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:402 | 402 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-444 | 70092-444-05 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:402 | 402 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5060 | 71266-5060-1 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:402 | 402 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-094 | 70092-094-36 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:402 | 402 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-099 | 70092-099-49 | Fentanyl Citrate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:403 | 403 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-378 | 73693-378-01 | ESTRADIOL 25MG | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:403 | 403 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0210 | 71283-0210-3 | Cholecalciferol | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:403 | 403 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-003 | 72055-003-01 | Ephedrine Sulfate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:403 | 403 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6276 | 71266-6276-3 | Epinephrine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:403 | 403 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6030 | 71285-6030-1 | Epinephrine | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:403 | 403 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 33216-836 | 33216-836-05 | Ephedrine Sulfate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:403 | 403 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:403 | 403 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-094 | 70092-094-36 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:403 | 403 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-5 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:403 | 403 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5343 | 26436-5343-1 | Estriol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:403 | 403 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-056 | 70713-056-01 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:403 | 403 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:403 | 403 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-099 | 70092-099-49 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:403 | 403 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5005 | 71266-5005-1 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:403 | 403 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-092 | 70092-092-36 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:403 | 403 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9170 | 71266-9170-6 | Fentanyl Citrate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:404 | 404 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-6028 | 26436-6028-3 | Procaine Hydrochloride | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:404 | 404 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0251 | 71283-0251-3 | Cholecalciferol | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:404 | 404 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6004 | 71286-6004-1 | Ephedrine Sulfate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:404 | 404 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-620 | 70004-620-12 | Esmolol Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:404 | 404 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-925 | 69374-925-10 | Epinephrine | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:404 | 404 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:404 | 404 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:404 | 404 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-9010 | 60652-9010-1 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:404 | 404 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-2 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:404 | 404 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5325 | 26436-5325-1 | Estriol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:404 | 404 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-131 | 70713-131-01 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:404 | 404 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1013 | 73013-1013-1 | Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:404 | 404 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-098 | 70092-098-44 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:404 | 404 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5050 | 71266-5050-1 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:404 | 404 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-093 | 70092-093-37 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:404 | 404 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:405 | 405 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83298-348 | 83298-348-10 | Norepinephrine Bitartrate | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:405 | 405 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cholecalciferol | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:405 | 405 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6003 | 71286-6003-1 | Ephedrine Sulfate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:405 | 405 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Esmolol Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:405 | 405 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:405 | 405 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:405 | 405 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:405 | 405 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1318 | 61141-1318-1 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:405 | 405 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2074 | 71286-2074-1 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:405 | 405 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5228 | 26436-5228-3 | Estriol; Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:405 | 405 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0020 | 73271-0020-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:405 | 405 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1001 | 73013-1001-1 | Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:405 | 405 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-509 | 70092-509-35 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:405 | 405 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:405 | 405 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-250 | 70092-250-75 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:405 | 405 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:406 | 406 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-145 | 82396-145-25 | Lorazepam | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:406 | 406 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cholecalciferol | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:406 | 406 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6003 | 71286-6003-2 | Ephedrine Sulfate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:406 | 406 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Esmolol Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:406 | 406 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-544 | 69374-544-10 | Epinephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:406 | 406 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3084 | 62295-3084-7 | Ephedrine Sulfate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:406 | 406 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:406 | 406 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:406 | 406 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2073 | 71286-2073-1 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:406 | 406 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0929 | 26436-0929-1 | Estriol; Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:406 | 406 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0025 | 73271-0025-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:406 | 406 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1016 | 73013-1016-1 | Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:406 | 406 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-664 | 70092-664-74 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:406 | 406 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:406 | 406 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-103 | 73177-103-04 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:406 | 406 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1081 | 73013-1081-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:407 | 407 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0404 | 71285-0404-1 | Trophamine 3% / Dextrose 10% 250ml in 250ml bag | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:407 | 407 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Choline Chloride; Inositol; Methionine | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:407 | 407 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7018 | 72196-7018-1 | Epinephrine | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:407 | 407 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Esmolol Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:407 | 407 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-306 | 69374-306-10 | Epinephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:407 | 407 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3084 | 62295-3084-5 | Ephedrine Sulfate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:407 | 407 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-107 | 73702-107-15 | Ephedrine Sulfate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:407 | 407 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:407 | 407 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:407 | 407 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5553 | 26436-5553-3 | Estriol; Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:407 | 407 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0375 | 73271-0375-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:407 | 407 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-097 | 70092-097-43 | Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:407 | 407 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:407 | 407 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:407 | 407 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-103 | 73177-103-16 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:407 | 407 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1019 | 73013-1019-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:408 | 408 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-013 | 73198-013-10 | T-106 | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:408 | 408 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Choline Chloride; Methionine; Inositol; Cyanocobalamin | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:408 | 408 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7019 | 71285-7019-1 | Epinephrine | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:408 | 408 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-006 | 69761-006-01 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:408 | 408 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine Hydrochloride; Lidocaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:408 | 408 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:408 | 408 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:408 | 408 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:408 | 408 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:408 | 408 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5502 | 26436-5502-3 | Estriol; Testosterone; Estradiol; Progesterone | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:408 | 408 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0015 | 73271-0015-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:408 | 408 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-05 | Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:408 | 408 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:408 | 408 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-664 | 70092-664-74 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:408 | 408 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-103 | 73177-103-07 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:408 | 408 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1023 | 73013-1023-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:409 | 409 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0001 | 26436-0001-1 | Sildenafil | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:409 | 409 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cisatracurium Besylate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:409 | 409 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:409 | 409 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-010 | 69761-010-01 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:409 | 409 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-127 | 71449-127-32 | Epinephrine; Bupivacaine Hydrochloride; Dexamethasone Sodium Phosphate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:409 | 409 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6003 | 71286-6003-2 | Ephedrine Sulfate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:409 | 409 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:409 | 409 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:409 | 409 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:409 | 409 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-327 | 70324-327-01 | Fentanyl | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:409 | 409 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-051 | 70713-051-01 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:409 | 409 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-103 | 73177-103-16 | Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:409 | 409 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:409 | 409 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:409 | 409 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-27 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:409 | 409 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1014 | 73013-1014-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:410 | 410 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2554 | 72934-2554-2 | Abenor | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:410 | 410 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Clindamycin Phosphate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:410 | 410 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:410 | 410 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-015 | 69761-015-01 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:410 | 410 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine; Lidocaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:410 | 410 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6003 | 71286-6003-1 | Ephedrine Sulfate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:410 | 410 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:410 | 410 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:410 | 410 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:410 | 410 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-327 | 70324-327-02 | Fentanyl | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:410 | 410 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0022 | 73271-0022-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:410 | 410 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-103 | 73177-103-05 | Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:410 | 410 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-097 | 70092-097-43 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:410 | 410 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:410 | 410 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-03 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:410 | 410 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:411 | 411 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6514 | 72934-6514-2 | Mokura | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:411 | 411 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Clindamycin Phosphate; Azelaic Acid | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:411 | 411 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:411 | 411 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-018 | 69761-018-01 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:411 | 411 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine; Lidocaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:411 | 411 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:411 | 411 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:411 | 411 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:411 | 411 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1318 | 61141-1318-1 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:411 | 411 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-5010 | 70214-5010-1 | Fentanyl | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:411 | 411 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0006 | 73271-0006-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:411 | 411 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-103 | 73177-103-04 | Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:411 | 411 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-100 | 70092-100-50 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:411 | 411 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:411 | 411 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-05 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:411 | 411 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:412 | 412 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-433 | 70092-433-50 | RECK in 50 ml NaCl- 50 ml syr | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:412 | 412 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Clindamycin Phosphate; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:412 | 412 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-027 | 70324-027-01 | Epinephrine | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:412 | 412 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-022 | 69761-022-01 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:412 | 412 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6276 | 71266-6276-3 | Epinephrine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:412 | 412 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:412 | 412 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:412 | 412 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:412 | 412 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:412 | 412 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-202 | 73702-202-02 | Fentanyl | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:412 | 412 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0018 | 73271-0018-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:412 | 412 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-103 | 73177-103-28 | Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:412 | 412 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-886 | 69194-886-01 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:412 | 412 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-097 | 70092-097-43 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:412 | 412 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-910 | 71170-910-25 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:412 | 412 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-160 | 70092-160-37 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:413 | 413 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6647 | 71300-6647-3 | NALTREXONE HYDROCHLORIDE | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:413 | 413 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Clindamycin Phosphate; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:413 | 413 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-077 | 70324-077-01 | Epinephrine | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:413 | 413 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-025 | 69761-025-01 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:413 | 413 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Esmolol | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:413 | 413 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:413 | 413 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:413 | 413 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:413 | 413 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5010 | 71266-5010-1 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 |